StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.43−0.07 (-13.14%)

Close on Nov 17, 2026Market cap $14.51MP/E –Yield –

Pasithea Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Pasithea Therapeutics's profit margin for the twelve months ending Dec 31, 2022 was -2864.3%. For fiscal 2022 it was -2864.3%, against -14430.5% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-2864.3%+11566.2
FY2021Dec 31, 2021-14430.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2022Dec 31, 2022-2126.1%–
Q3 FY2022Sep 30, 2022-2097.9%–
Q2 FY2022Jun 30, 2022-19574.4%–
Q1 FY2022Mar 31, 2022-11526.1%–

More Pasithea Therapeutics figures

See a number that looks wrong?